Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review

Vulvar cancer (VC) is a rare neoplasm, usually arising in postmenopausal women, although human papilloma virus (HPV)-associated VC usually develop in younger women. Incidences of VCs are rising in many countries. Surgery is the cornerstone of early-stage VC management, whereas therapies for advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Borella, Fulvio, Preti, Mario, Bertero, Luca, Collemi, Giammarco, Castellano, Isabella, Cassoni, Paola, Cosma, Stefano, Carosso, Andrea Roberto, Bevilacqua, Federica, Gallio, Niccolò, Benedetto, Chiara, Micheletti, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796178/
https://www.ncbi.nlm.nih.gov/pubmed/33375467
http://dx.doi.org/10.3390/ijms22010190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796178/
https://www.ncbi.nlm.nih.gov/pubmed/33375467
http://dx.doi.org/10.3390/ijms22010190

Ejemplares similares